BI-1935 is primarily utilized in the field of medical research, particularly in the study of cancer therapies. It functions as a potent and selective inhibitor that targets specific pathways involved in tumor growth and survival. Researchers employ BI-1935 to investigate its potential in disrupting these pathways, thereby inhibiting the proliferation of cancer cells. Its application is crucial in preclinical studies to evaluate efficacy, safety, and mechanisms of action, contributing to the development of novel anticancer drugs. Additionally, it aids in understanding the molecular basis of cancer, which can lead to the identification of new therapeutic targets. BI-1935 is also used in combination studies with other agents to assess synergistic effects and improve treatment outcomes.